Myeloma and Related Diseases Registry (MRDR)

Helping clinicians and hospitals to provide the best possible care to people with multiple myeloma and related diseases.

More information

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

6943

Patients accrued

4860

Patients with multiple myeloma

59

Number of approved sites

664

M1000 Biobank participants

Latest news

Rare Disease Day - Thursday 29th Feb!
23 Feb 2024

The MRDR supports Rare Disease Day 2024.

Read more
World Cancer Day - 4th February 2024
02 Feb 2024

The MRDR supports World Cancer Day.

Read more
New MRDR Publication on Real-world outcomes in RRMM patients
02 Feb 2024

Sueh-li Lim's paper on Real-world outcomes in relapsed refractory multiple myeloma patients exposed to three or more prior treatments has been published.

Read more
MRDR at Blood 2023
10 Nov 2023

The MRDR was well-represented at Blood 2023!

Read more

Participating organisations